Fig. 12From: Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental dataFitting the model to lung cancer data. Graphical representation of the fitting results of the vascular tumour growth and response to bevacizumab treatment model to experimental data concerning lung tumour xenografts [61]Back to article page